Items where authors include "Naik, S."
Article
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736
Naik, S., Wood, A.R., Ongenaert, M. et al. (7 more authors) (2021) A 3d renal proximal tubule on chip model phenocopies Lowe syndrome and Dent II disease tubulopathy. International Journal of Molecular Sciences, 22 (10). 5361. ISSN 1661-6596
Sharma, S., Carmona, A., Skowronek, A. et al. (6 more authors) (2019) Apoptotic signalling targets the post-endocytic sorting machinery of the death receptor Fas/CD95. Nature Communications, 10 (1).
McRae, J.F., Clayton, S., Fitzgerald, T.W. et al. (299 more authors) (2017) Prevalence and architecture of de novo mutations in developmental disorders. Nature, 542 (7642). pp. 433-438. ISSN 0028-0836
Preprint
Copeland, H., Low, K.J., Wynn, S. et al. (89 more authors) (2023) Large-scale evaluation of outcomes following a genetic diagnosis in children with severe developmental disorders. [Preprint] (Submitted)